Patents Assigned to BioAvivus, LLT
  • Patent number: 9649289
    Abstract: The present invention is the treatment of dysbiosis and related disease states caused by or made worse by dysbiosis, using an oral treatment of nanosized salsalate particles.
    Type: Grant
    Filed: August 16, 2016
    Date of Patent: May 16, 2017
    Assignee: BioAvivus, LLT
    Inventor: Charles W. Vaughn